The pilot study of SGLT2 selective inhibitor therapy for NAFLD patients who were complicated with T2DM
Not Applicable
- Conditions
- AFLD patients who were complicated with T2DM
- Registration Number
- JPRN-UMIN000023574
- Lead Sponsor
- Department of Hepatology, Shimane University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Chronic liver disease cases other than the non-alcoholic fatty liver disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c after 6 months from the start of the administration.
- Secondary Outcome Measures
Name Time Method Body weight, body composition, ASTand ALT after 6 months from the start of the administration.